跳至主要内容
临床试验/NCT01117792
NCT01117792已完成不适用

Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation

Boston Scientific Corporation8 个研究点 分布在 4 个国家目标入组 55 人开始时间: 2008年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
55
试验地点
8
主要终点
Conversion of Induced Ventricular Fibrillation

研究概览

简要总结

The primary objective is to evaluate the S-ICD system's ability to identify and terminate induced ventricular fibrillation in patients during the implant procedure. The safety and performance of the S-ICD system will also be assessed throughout the patient follow-up period.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Replacement of an existing implanted transvenous ICD system
  • •Class I, Class IIa, or Class IIb ACC/AHA/HRS indications for patients without an existing transvenous ICD system
  • •Age is >= 18 years
  • •Appropriate pre-operative ECG as measured with a specially developed template

排除标准

  • •Subjects unable or unwilling to provide informed consent
  • •Any condition which precludes the subject's ability to comply with the study requirements
  • •Females who are pregnant or lactating and pre-menopausal women who are unwilling to use adequate birth control for the duration of the study
  • •Participation in another investigational device trial at any time during the conduct of the S-ICD system trial without written consent from the sponsor.
  • •Patients with a serious medical condition and life expectancy of less than one year.
  • •Patients with documented spontaneous and frequently recurring VT that is reliably terminated with anti-tachycardia pacing
  • •Patients with existing epicardial patches or subcutaneous electrodes in the left thoracic quadrant
  • •Patients with impaired kidney function as measured by a Cockcroft-Gault Glomerular Filtration Rate (GFR) with a GFR <= 29.

研究组 & 干预措施

S-ICD System

Experimental

干预措施: subcutaneous implantable defibrillator (S-ICD) system (Device)

结局指标

主要结局

Conversion of Induced Ventricular Fibrillation

时间窗: Testing done during the implant procedure

The total number of subjects the S-ICD System was successful at converting induced sustained ventricular fibrillation.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验